ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada2026
Sperm banking in testicular cancer survivors Low utilization, high costs, and patient-reported barriers from a Canadian cohort.
Article in Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionTesticular cancer (TC) affects young men in their reproductive years. Although sperm cryopreservation is recommended before treatment, real-world utilization and patient experiences in Canada remain poorly described.
methodsWe conducted a retrospective chart review with a prospective telephone survey of men with TC who underwent sperm cryopreservation (2007-2019) at Manitoba's sole fertility preservation center. Demographic, treatment, and semen parameters were abstracted from medical records. A structured questionnaire assessed counseling, decision-making, costs, banked sperm utilization, and fertility outcomes.
resultsOf 42 eligible men, 24 (57%) completed the survey. The mean age at banking was 25.6 years. Most (71%) received chemotherapy in addition to orchiectomy; 29% underwent orchiectomy alone. Only two men (8%) banked sperm before orchiectomy; the remainder did so prior to systemic therapy. Abnormal semen parameters were common (79%), with a median sperm concentration (13.0 million/mL, interquartile range [IQR] 3.0-21.5) and total sperm count (14.8 million, IQR 8.6-84.9) below World Health Organization (WHO) 2021 limits. Counseling occurred for 88% of men, although half felt rushed in their decision-making. The mean cost was approximately $2000 over three years, and 58% found this burdensome. Only three men (13%) used their cryopreserved sperm, all after chemotherapy, each resulting in a live birth through assisted reproductive technology. Eleven men (46%) conceived naturally after treatment, eight (33%) had not yet attempted conception.
conclusionsIn this Canadian cohort, sperm banking utilization was low, and most survivors achieved natural conception. Financial burden and decisional stress were frequent. Enhanced counseling and public funding for fertility preservation may improve equitable access and survivorship care.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.